58
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Clinically significant drug interactions

What you need to know before writing prescriptions

, PharmD, , MD & , PharmD
Pages 193-222 | Published online: 30 Jun 2015

References

  • Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995;155(18): 1949–56
  • Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277(4): 301–6
  • Bates DW, Cullen DJ, Laird N, et al, for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995; 274(1): 29–34
  • Leape LL, Bates DW, Cullen DJ, et al, for the ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA 1995; 274(1): 35–43
  • Bates DW, Spell N, Cullen DJ, et al, for the Adverse Drug Events Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA 1997; 277(4): 307–11
  • Asch DA, Parker RM. The Libby Zion case: one step forward or two steps backward? N Engl J Med 1988; 318(12): 771–5
  • Meperidine and phenelzine manufacturer's package insert information. In: Physicians' desk reference. 51st ed. Montvale, NJ: Medical Economics, 1997
  • Headden S, Lenzy T, Lostyu P, et al. Danger at the drugstore. US News and World Report 1996 Aug 26
  • Slaughter RL, Edwards DJ. Recent advances: the cytochrome P450 enzymes. Ann Pharmacother 1995; 29(6): 619–24
  • Krishna DR, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994; 26(2): 144–60
  • Nebert DW, Adesnik M, Coon MJ, et al. The P450 gene superfamily: recommended nomenclature. DNA 1987; 6(1): 1–11
  • Slaughter RL. Clinical relevance of cytochrome P450 enzymes. Hosp Pharm Times 1996 Jul; 6–15HPT
  • Gillum JG, Israel DS, Polk RE. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 1993; 25(6): 450–82
  • Cupp MJ, Tracy TS. Role of the cytochrome P4503A subfamily in drug interactions. US Pharmacist 1997 Jan; HS9–21
  • Dossing M, Pilsgaard H, Rasmussen B, et al. Time course of phenobarbital and Cimetidine mediated changes in hepatic drug metabolism. Eur J Clin Pharmacol 1983; 25(2): 215–22
  • Parkinson A. Biotransformation of Xenobiotics. In: Klaassen CD, Amdur MO, Doull J, eds. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. New York: McGraw-Hill, 1996, chap 6
  • Quinn DI, Day RO. Drug interactions of clinical importance: an updated guide. Drug Saf 1995; 12(6): 393–452
  • Riesenman C. Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy 1995; 15(6 Pt 2): 84–99S
  • Ereshefsky L. Drug interactions of antidepressants. Psychiatric Annals 1996; 26(6): 342–50
  • GI stimulants: cisapride. In: Olin BR, ed. Drug facts and comparisons. St Louis: Drug Facts and Comparisons, 1996: 308b–e

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.